Cel-Sci Corporation (NYSE AMERICAN: CVM)
$1.49
+0.1750 ( +13.36% ) 719.1K
CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development at developing the treatment of cancer and other diseases by using the immune system. The Company's core capabilities that include are drug discovery, research, development and manufacturing of complex biological substances. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.
Market Data
Open
$1.49
Previous close
$1.31
Volume
719.1K
Market cap
$81.24M
Day range
$1.31 - $1.59
52 week range
$1.04 - $3.23
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Jul 01, 2024 |
4 | Insider transactions | 1 | Jul 01, 2024 |
4 | Insider transactions | 1 | Jul 01, 2024 |
8-k | 8K-related | 19 | Jun 20, 2024 |
10-q | Quarterly Reports | 57 | May 15, 2024 |
4 | Insider transactions | 1 | May 10, 2024 |
4 | Insider transactions | 1 | May 09, 2024 |
4 | Insider transactions | 1 | May 09, 2024 |
4 | Insider transactions | 1 | Apr 23, 2024 |
4 | Insider transactions | 1 | Apr 23, 2024 |